Atlas Trials

A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer

Clinical trial NCT03306472 · COMPLETED

Trial details

NCT number
NCT03306472
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-07-20
Primary completion
2022-10-31
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.